These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials. Alden RS; Mandrekar SJ; Oxnard GR Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304 [TBL] [Abstract][Full Text] [Related]
5. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials. Quant EC; Wen PY Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556 [TBL] [Abstract][Full Text] [Related]
6. Introduction to special issue on biomarker-based clinical trial designs in oncology. Sargent DJ; Mandrekar S; Grothey A Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295 [No Abstract] [Full Text] [Related]
7. Improved strategies for designing lupus trials with targeted therapies: learning from 65 years of experience. Wallace DJ Lupus; 2016 Sep; 25(10):1141-9. PubMed ID: 27497258 [TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology Developing First Clinical Trial. Brower V J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625 [No Abstract] [Full Text] [Related]
9. An overview of the NCI precision medicine trials-NCI MATCH and MPACT. Do K; O'Sullivan Coyne G; Chen AP Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298 [TBL] [Abstract][Full Text] [Related]
10. NCI-MATCH launch highlights new trial design in precision-medicine era. McNeil C J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446 [No Abstract] [Full Text] [Related]
11. Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies. Lin JA; He P Br Med Bull; 2015 Jun; 114(1):17-27. PubMed ID: 25921239 [TBL] [Abstract][Full Text] [Related]
13. Expanding rare disease drug trials based on shared molecular etiology. Brooks PJ; Tagle DA; Groft S Nat Biotechnol; 2014 Jun; 32(6):515-8. PubMed ID: 24911489 [No Abstract] [Full Text] [Related]
14. Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials. Zwierzina H; Bardelli A; Ciardiello F; Gariboldi M; HĂ„kansson L; Lambrechts D; Lind GE; Loeffler-Ragg J; Schmoll H; Siena S; Tabernero J; Van Cutsem E Curr Opin Mol Ther; 2010 Dec; 12(6):703-11. PubMed ID: 21154162 [TBL] [Abstract][Full Text] [Related]
15. An overview of the design and conduct of the BATTLE trials. Liu S; Lee JJ Chin Clin Oncol; 2015 Sep; 4(3):33. PubMed ID: 26408300 [TBL] [Abstract][Full Text] [Related]
16. Genomic research advances pancreatic cancer's early detection and treatment. Brower V J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142448 [No Abstract] [Full Text] [Related]
17. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy. Farwell MD; Clark AS; Mankoff DA JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243 [No Abstract] [Full Text] [Related]
18. [Adaptive designs for clinical trial]. Li W; He SJ; Wang Y; Cheng XR; Jia X Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun; 28(6):605-7. PubMed ID: 17939395 [TBL] [Abstract][Full Text] [Related]
20. Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology. Marconato L; Buracco P; Aresu L Vet J; 2015 Aug; 205(2):238-43. PubMed ID: 25862396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]